Sirtuin and metabolic kidney disease

Slides:



Advertisements
Similar presentations
Nad metabolites The pyridine dinucleotide, NAD+, is a substrate of sirtuins and coenzyme for hydride transfer enzymes and other NAD+-dependent ADP ribose.
Advertisements

Originally defined as a molecular fraction (“cozymase”) that accelerated fermentation in yeast extracts.
Toward the development of podocyte-specific drugs
Figure 1 Cardiac and renal biosynthesis and
Sirtuins and the Metabolic Hurdles in Cancer
NAD+ Metabolism and the Control of Energy Homeostasis: A Balancing Act between Mitochondria and the Nucleus  Carles Cantó, Keir J. Menzies, Johan Auwerx 
The Case ∣ Acute renal failure and anemia
Driving change: kidney proximal tubule CSF-1 polarizes macrophages
Primary proximal tubule injury leads to epithelial cell cycle arrest, fibrosis, vascular rarefaction, and glomerulosclerosis  Joseph V. Bonventre  Kidney.
Volume 58, Issue 1, Pages (July 2000)
Ding Ai, John Y.-J. Shyy, Yi Zhu  Kidney International 
Why NAD+ Declines during Aging: It’s Destroyed
Beyond genetics: epigenetic code in chronic kidney disease
Innate immunity as a driving force in renal disease
Figure 2 The potential effects of nicotinamide adenine
Volume 93, Issue 1, Pages (January 2018)
In Vino Veritas: A Tale of Two Sirt1s?
Jean-Pierre Etchegaray, Raul Mostoslavsky  Molecular Cell 
Ketone bodies as signaling metabolites
Renoprotective effects of vitamin D analogs
AROuSing SIRT1: Identification of a Novel Endogenous SIRT1 Activator
JAK/STAT signaling in renal diseases
Discoveries of Nicotinamide Riboside as a Nutrient and Conserved NRK Genes Establish a Preiss-Handler Independent Route to NAD+ in Fungi and Humans  Pawel.
Figure 6 Cross-compartmental junctions in cellular NAD+ metabolism
Programmed anti-inflammatory macrophages protect against AKI and promote repair through trophic actions  Christof Westenfelder  Kidney International 
Volume 86, Issue 4, Pages (October 2014)
Glucose Restriction: Longevity SIRTainly, but without Building Muscle?
Volume 70, Issue 7, Pages (October 2006)
Mitochondria: In Sickness and in Health
Sanjeev Noel, Abdel R.A. Hamad, Hamid Rabb  Kidney International 
Toward the development of podocyte-specific drugs
Volume 76, Issue 11, Pages (December 2009)
Silencing Insulin Resistance through SIRT1
The salvage/recycling pathway for NAD+ biosynthesis from nicotinamide riboside (NR) in manNR, taken in to the body, can be converted to nicotinamide mononucleotide.
Volume 76, Issue 8, Pages (October 2009)
Conserved Metabolic Regulatory Functions of Sirtuins
Volume 80, Issue 8, Pages (October 2011)
Pierre Theurey, Jennifer Rieusset  Trends in Endocrinology & Metabolism 
SIRT1 Synchs Satellite Cell Metabolism with Stem Cell Fate
Karsten Bartels, Almut Grenz, Holger K. Eltzschig  Kidney International 
Qingqing Wei, Zheng Dong  Kidney International 
Epigenetic Control of Autophagy: Nuclear Events Gain More Attention
Macrophages and hypoxia in human chronic kidney disease
Special deLIVERy: podocyte injury promotes renal angiotensin II generation from liver- derived angiotensinogen  David I. Ortiz-Melo, Robert F. Spurney 
Organelle crosstalk in the kidney
Toshimasa Yamauchi, Takashi Kadowaki  Cell Metabolism 
Driving change: kidney proximal tubule CSF-1 polarizes macrophages
Volume 74, Issue 8, Pages (October 2008)
Calcium sensing in podocytes
Nat. Rev. Endocrinol. doi: /nrendo
Volume 87, Issue 1, Pages (January 2015)
Matrix metalloproteinases and matrix receptors in progression and reversal of kidney disease: therapeutic perspectives  Pierre Ronco, Christos Chatziantoniou 
Volume 75, Issue 9, Pages (May 2009)
Florian E. Togel, Christof Westenfelder 
New paradigms in cell death in human diabetic nephropathy
Advances in the pathogenesis of HIV-associated kidney diseases
Volume 82, Issue 9, Pages (November 2012)
NODding off in acute kidney injury with progranulin?
Volume 76, Issue 5, Pages (September 2009)
Is complement a target for therapy in renal disease?
A nest in renal fibrosis?
Volume 85, Issue 3, Pages (March 2014)
Volume 84, Issue 6, Pages (December 2013)
Cross-regulation of Signaling Pathways by Interferon-γ: Implications for Immune Responses and Autoimmune Diseases  Xiaoyu Hu, Lionel B. Ivashkiv  Immunity 
AROuSing SIRT1: Identification of a Novel Endogenous SIRT1 Activator
Volume 72, Issue 8, Pages (October 2007)
DisSIRTing on LXR and Cholesterol Metabolism
Therapeutic strategies targeting NAMPT against stroke.
Novel targets for mitochondrial medicine
Tomohiro Tanaka, Yo-ichi Nabeshima  Cell Metabolism 
Presentation transcript:

Sirtuin and metabolic kidney disease Shu Wakino, Kazuhiro Hasegawa, Hiroshi Itoh  Kidney International  Volume 88, Issue 4, Pages 691-698 (October 2015) DOI: 10.1038/ki.2015.157 Copyright © 2015 International Society of Nephrology Terms and Conditions

Figure 1 Sirtuins and their functions. Sirtuin, a mammalian homolog of the Sir2 gene in yeasts, comprises seven isoforms. Sirt1, 6, and 7 are located predominantly in the nucleus, Sirt2 in cytoplasm, and Sirt3, 4, and 5 in mitochondria. These genes are activated or induced by calorie restriction or by acute cellular stresses mainly through increased levels of NAD+, thereby having a function in cellular survival. Changes contribute to longevity and organ protection. NAD, nicotine amide dinucleotide; Sirt, Sirtuin. Kidney International 2015 88, 691-698DOI: (10.1038/ki.2015.157) Copyright © 2015 International Society of Nephrology Terms and Conditions

Figure 2 Nicotinic acid metabolism. NAD+, an essential factor in cellular respiration and metabolism, is produced through metabolism of nicotinic acid. NAD+ is synthesized via a de novo pathway from essential amino acid. NAD+ is also recycled through a salvage pathway where iNAMPT acts as a rate-limiting enzyme. In case NAD+ salvage was insufficient, Sirt1 activity decreased, further downregulating iNAMPT activity and salvage pathway. NAD, nicotine amide dinucleotide; Npt, nicotinic acid phosphoribosyltransferase; NaMN, nicotinic acid mononucleotide; Nmnat, nicotinamide mononucleotide adenylyltransferase; NMN, nicotinamide mononucleotide; iNAMPT, intracellular nicotinamide phosphoribosyltransferase; NMNAM, n-methylnicotinamide; Nnmt, nicotinamide n-methyltransferase. Kidney International 2015 88, 691-698DOI: (10.1038/ki.2015.157) Copyright © 2015 International Society of Nephrology Terms and Conditions

Figure 3 Tubule–glomeruli communication hypothesis. Primary downregulation of Sirtuin (Sirt1) or iNAMPT reflects metabolic disruption of proximal tubular cells in the diabetic condition and initiates albuminuria. This downregulation decreases NMN excretion from proximal tubules, which is taken up by podocytes upstream and close to proximal tubules. Reduced uptake levels of NMN decrease Sirt1 expression in podocytes, which epigenetically upregulate claudin-1 expression through increased acetylation of histone H3K9 and through the hypermethylation of the claudin-1 gene CpG island. Ectopic overexpression of claudin-1 in podocytes disrupts the slit membrane structure via reduced expression of synaptopodin and podocin. This molecular change leads to changes in the podocyte structure and foot process effacement. Finally, the molecular events propagating proximal tubular cells to podocytes initiate albuminuria in diabetic nephropathy. NMN, nicotinamide mononucleotide; iNAMPT, intracellular nicotinamide phosphoribosyltransferase. Kidney International 2015 88, 691-698DOI: (10.1038/ki.2015.157) Copyright © 2015 International Society of Nephrology Terms and Conditions

Figure 4 Scheme depicting the role of sirtuin in kidney disease. Sirt1 and Sirt3 have significant roles in the pathogenesis of various kidney diseases and in renal damage. These effects were targeted at various sites or cells of the kidney and at various downstream molecules that were subject to deacetylation or epigenetic gene regulation by sirtuin. AKI, acute kidney injury; MMP14, matrix metalloproteinase 14; NF-κB, nuclear factor-κB; PGC-1α, peroxisome proliferator-activated receptor gamma coactivator 1-alpha; Sirt, Sirtuin. Kidney International 2015 88, 691-698DOI: (10.1038/ki.2015.157) Copyright © 2015 International Society of Nephrology Terms and Conditions